Search results for "Reimbursement Mechanisms"

showing 2 items of 2 documents

Clinical review: impact of statin substitution policies on patient outcomes.

2009

Background. The increasing awareness of cost issues in health care has led to the increasing use of policy-driven substitution of branded for generic medications, particularly relative to statin treatment for cardiovascular diseases. While there are potential short-term health care savings, the consequences for primary care are under-researched. Our objective was to review data on intensive statin therapy and generic substitution in patients at high cardiovascular risk. Results. Current treatment guidelines for the prevention of cardiovascular disease are consistent in their recommendations regarding statin therapy and treatment targets. Clinical trials demonstrate that to reduce cardiovasc…

medicine.medical_specialtyStatinCost effectivenessmedicine.drug_classDiseasePlaceboReimbursement MechanismsRisk FactorsHealth caremedicineDrugs GenericHumanscardiovascular diseasesIntensive care medicinebusiness.industryPublic healthHealth Policynutritional and metabolic diseasesGeneral MedicineClinical trialEuropeCardiovascular DiseasesPractice Guidelines as TopicPhysical therapyObservational studylipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsbusiness
researchProduct

Reimbursement of radiotherapy in Germany.

2017

Reimbursement of radiotherapy in Germany is mainly based on a certain fixed fee for treatment planning and patient set up in addition to payment per fraction. This applies to outpatient care for patients with public health insurance or private health insurance. Payment per fraction has a considerable influence on reimbursement of inpatients as well. The advantage of payment per fraction is the simplicity and transparency. The disadvantage is an inadequate reimbursement for new treatment modalities like hypofractionation or stereotactic body radiotherapy.

medicine.medical_specialtyTransparency (market)media_common.quotation_subjectmedicine.medical_treatmentReimbursement Mechanisms03 medical and health sciences0302 clinical medicineAmbulatory careGermanyMedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineRadiation treatment planningIntensive care medicinehealth care economics and organizationsDisadvantageReimbursementmedia_commonRadiotherapybusiness.industryPaymentRadiation therapyOncology030220 oncology & carcinogenesisbusinessStereotactic body radiotherapyCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
researchProduct